Weizman A

References (5)

Title : Opposing effects of oxytocin on overt compliance and lasting changes to memory - Edelson_2015_Neuropsychopharmacology_40_966
Author(s) : Edelson MG , Shemesh M , Weizman A , Yariv S , Sharot T , Dudai Y
Ref : Neuropsychopharmacology , 40 :966 , 2015
Abstract : Edelson_2015_Neuropsychopharmacology_40_966
ESTHER : Edelson_2015_Neuropsychopharmacology_40_966
PubMedSearch : Edelson_2015_Neuropsychopharmacology_40_966
PubMedID: 25308350

Title : Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia - Stryjer_2012_Clin.Neuropharmacol_35_161
Author(s) : Stryjer R , Ophir D , Bar F , Spivak B , Weizman A , Strous RD
Ref : Clinical Neuropharmacology , 35 :161 , 2012
Abstract : Stryjer_2012_Clin.Neuropharmacol_35_161
ESTHER : Stryjer_2012_Clin.Neuropharmacol_35_161
PubMedSearch : Stryjer_2012_Clin.Neuropharmacol_35_161
PubMedID: 22751086

Title : Fear thou not: activity of frontal and temporal circuits in moments of real-life courage - Nili_2010_Neuron_66_949
Author(s) : Nili U , Goldberg H , Weizman A , Dudai Y
Ref : Neuron , 66 :949 , 2010
Abstract : Nili_2010_Neuron_66_949
ESTHER : Nili_2010_Neuron_66_949
PubMedSearch : Nili_2010_Neuron_66_949
PubMedID: 20620879

Title : Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study - Stryjer_2004_Hum.Psychopharmacol_19_343
Author(s) : Stryjer R , Strous R , Bar F , Shaked G , Shiloh R , Rozencwaig S , Grupper D , Buchman N , Kotler M , Rabey JM , Weizman A
Ref : Hum Psychopharmacol , 19 :343 , 2004
Abstract : Stryjer_2004_Hum.Psychopharmacol_19_343
ESTHER : Stryjer_2004_Hum.Psychopharmacol_19_343
PubMedSearch : Stryjer_2004_Hum.Psychopharmacol_19_343
PubMedID: 15252826

Title : Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia - Stryjer_2003_Clin.Neuropharmacol_26_12
Author(s) : Stryjer R , Strous RD , Bar F , Werber E , Shaked G , Buhiri Y , Kotler M , Weizman A , Rabey JM
Ref : Clinical Neuropharmacology , 26 :12 , 2003
Abstract : Stryjer_2003_Clin.Neuropharmacol_26_12
ESTHER : Stryjer_2003_Clin.Neuropharmacol_26_12
PubMedSearch : Stryjer_2003_Clin.Neuropharmacol_26_12
PubMedID: 12567159